PRIMO 2017
Register Now

The Practical Recommendations in Immuno and Molecular Oncology Conference

Is a unique opportunity to receive CME credits while staying ahead of the latest advances in immuno and molecular oncology.

The Annual PRIMO Meeting is designed to summarize key developments in cancer care over the past 12 months, and feature expected advances that you and your patients will likely see in the upcoming year.

PRIMO Regional Meetings focus on recent advances specific to hematology. There are currently four regional PRIMO meetings available in different US regions — register for FREE today to earn credits before the end of 2016.


The 2018 agenda is being curated to meet the educational needs of all attendees with an emphasis on the follow key areas:

Practical considerations of applying biomarkers and targeted therapy
Integration of immunotherapy, with a focus on novel management approaches
Patient selection, as well as timing and sequencing of therapy
Dealing with important trends, such a big data and defining value in cancer care


An elite faculty is being assembled for the 2018 Annual PRIMO Meeting by our Steering Committee, led by our Co-Chairs Dr. Brahmer, Dr. Rugo, and Dr. Vose


Julie Brahmer, MD

Director, Thoracic Oncology Program
Interim Director, Johns Hopkins
Kimmel Cancer Center at Bayview
Associate Professor of Oncology
Sidney Kimmel
Comprehensive Cancer Center
Johns Hopkins School of Medicine Baltimore, MD

Hope S. Rugo, MD

Professor of Medicine
Director, Breast Oncology
and Clinical Trials Education
UCSF Helen Diller Family
Comprehensive Cancer Center
San Francisco, CA

Julie M. Vose, MD, MBA

Neumann M. and Mildred E.
Harris Professor
Chief Division of Hematology/ Oncology
Professor of Medicine
Nebraska Medical Center
Omaha, NE

Steering Committee

Sanjiv S. Agarwala, MD

Professor of Medicine
Chief Oncology & Hematology
St. Luke’s University Hospital and
Temple University
Philadelphia, PA

Charles M. Balch, MD FACS

Research Professor of Surgery
University of Texas
MD Anderson Cancer Center,
Houston, TX
Editor-in-Chief, Annals of Surgical Oncology

Sagar Lonial, MD

Department of Hematology
and Medical Oncology
Chief Medical Officer
Winship Cancer Institute
Emory University
Atlanta, GA

Alan P. Venook, MD

Professor of Medical Oncology
Chief, Gastrointestinal Oncology
UCSF Helen Diller Family
Comprehensive Cancer Center
San Francisco, CA

Exhibitors and Sponsors

The PRIMO Meetings offer a fantastic opportunity for industry leaders to interact with leading multidisciplinary oncologists, and stay up to date with the latest information regarding targeted and immunologic therapies.